TAU-IN-3 [CAS 3063511-09-8]

TAU-IN-3 (Compound 2) is an orally active TAU inhibitor. TAU-IN-3 inhibits the expression of MAPT exon 10 DDPAC mutant gene in HeLa cells (IC50: 0.6 µM) . TAU-IN-3 reduces the 4R/3R MAPT mRNA ratio in HeLa cells transfected with WT or DDPAC minigenes. TAU-IN-3 inhibits the insertion of endogenous MAPT exon 10 and the production of 4R tau protein in cells. TAU-IN-3 modulates tau splicing in htau mice and improves the associated behavioral phenotypes. TAU-IN-3 can be used to study neurodegenerative diseases[1].

[3063511-09-8]

C24H30N6O2

434.53

CN(C1=C2N=CN(CCCN(C)CCCC3=CN=C(N)C=C3OC)C1=O)C4=C2C=CC=C4

Tau Protein

Room temperature